How much funding has ORLANCE, INC raised?

ORLANCE, INC has raised $3.0M in total funding, most recently a Grant round.

Who are ORLANCE, INC's investors?

ORLANCE, INC's investors include National Institutes of Health.

When was ORLANCE, INC founded?

ORLANCE, INC was founded in 2018.

Where is ORLANCE, INC headquartered?

ORLANCE, INC is headquartered in SEATTLE, Washington, United States.

What industry is ORLANCE, INC in?

ORLANCE, INC operates in Biotech, Healthcare.

How many employees does ORLANCE, INC have?

ORLANCE, INC has 1-10 employees.

ORLANCE, INC

MACH-1™: Pow(d)ering your skin to deliver disease protection and treatment.

SEATTLE, United States · Founded 2018 · $3.0M raised

Biotech

Healthcare

Headquarters: SEATTLE, Washington
Employees: 1–10
Founded: 2018
Business Model: B2G

Website: orlance.com
Total Funding: $3.0M
Last Round: $3.0M GrantJan 2024
Rounds: 2

About

Orlance is a biotech company developing the MACH-1™ needle-free, powdered vaccine and immunotherapy delivery platform. Backed by $16.8M in NIH SBIR funding, MACH-1 delivers nucleic acid vaccines directly into the epidermis, eliminating cold chain requirements and reducing doses by up to 90%. Lead programs target influenza, cancer, and hepatitis B.

Summary

ORLANCE, INC is a Biotech company based in SEATTLE, United States, founded in 2018. It has raised $3.0M in total across 2 rounds, most recently a $3.0M Grant round in Jan 2024. Investors include National Institutes of Health.